LCTX insider trading

Open-market stock trades by Lineage Cell Therapeutics (LCTX) executives and directors: who bought or sold, how many shares, at what price and when.

LCTX insider trades

DateInsiderRoleTradeSharesPriceValue
Mar 12, 2026Culley Brian MPresident and CEOBuy15,000$1.62$24.38K
Jan 27, 2025BROADWOOD PARTNERS, L.P.Buy0–$0.00
Jan 27, 2025BROADWOOD PARTNERS, L.P.Buy7,894,737$0.76$6.00M
Jan 27, 2025BROADWOOD PARTNERS, L.P.Buy0$0.91$0.00
Nov 26, 2024Howe Jill AnnChief Financial OfficerBuy15,000$0.59$8.85K
Nov 26, 2024Samuel George A. IIIGeneral CounselBuy15,000$0.60$9.00K
Nov 22, 2024Mulroy Michael H.directorBuy40,000$0.57$22.64K
Nov 21, 2024Culley Brian MPresident and CEOBuy40,000$0.60$24.00K
Aug 16, 2024Howe Jill AnnChief Financial OfficerBuy10,500$0.89$9.35K
May 24, 2024Culley Brian MPresident and CEOBuy10,000$1.05$10.50K
Feb 8, 2024BAILEY DON MdirectorBuy96,155$1.04$100.00K
Feb 6, 2024BROADWOOD PARTNERS, L.P.Buy0–$0.00
Feb 6, 2024BROADWOOD PARTNERS, L.P.Buy6,730,770$1.04$7.00M
Dec 29, 2023Jayasuriya AnuladirectorBuy10,000$1.09$10.90K

Updated 2026-11-17 17:46 UTC